Why did Tesla shares plunge recently?
How are Trump tariffs impacting global trade?
What caused Procter & Gamble's recent job cuts?
Why is the Trump-Musk feud affecting markets?
How is Circle's IPO influencing crypto markets?
Why did ECB cut interest rates again?
What is behind Lululemon's profit forecast downgrade?
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point
benzinga.com/analyst-stock-ratings/upgrades/25/06/45778542/anaptysbios-arthritis-drug-matches-top-therapies-in-phase-2-trial-analyst-sees-tur
AnaptysBio, Inc. (NASDAQ:ANAB) on Tuesday released updated data from the Phase 2b trial of rosnilimab, a PD-1 depleter and agonist, for rheumatoid arthritis.
In the 424-patient 2b trial, rosnilimab achieved JAK-like efficacy on multiple clinically meaningful measures, including low…
This story appeared on benzinga.com, 2025-06-04 18:23:16.